|
|
|
Insider
Information: |
Sanofi-Aventis |
Relationship: |
10% Owner |
City: |
Paris |
State: |
I0 |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
11 |
|
Direct
Shares |
75,668,031 |
|
Indirect Shares
|
26,048,661 |
|
|
Direct
Value |
$2,826,957,638 |
|
|
Indirect Value
|
$1,877,527,091 |
|
|
Total
Shares |
101,716,692 |
|
|
Total
Value |
$4,704,484,729 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
1
|
5
|
Stock
price went up :
|
0
|
2
|
Stock
price went down : |
1
|
3
|
|
|
|
Gain/Loss Ratio : |
-1.0
|
-1.0
|
Percentage
Gain/Loss : |
-17.8%
|
-3.6%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Regulus Therapeutics Inc. |
RGLS |
10% Owner |
|
0 |
2014-02-04 |
5,053,779 |
Premium* |
|
Humanigen Inc |
HGEN |
Former 10% owner |
2013-01-31 |
0 |
2013-01-31 |
579,030 |
Premium* |
|
Glycomimetics Inc |
GLYC |
10% Owner |
|
0 |
2013-11-06 |
1,193,625 |
Premium* |
|
Regeneron Pharmaceuticals Inc |
REGN |
|
2020-05-29 |
0 |
2020-06-09 |
279,766 |
Premium* |
|
Alnylam Pharmaceuticals Inc |
ALNY |
10% Owner |
|
0 |
2017-05-31 |
10,554,134 |
Premium* |
|
Scynexis Inc |
SCYX |
10% Owner |
|
0 |
2014-05-07 |
1,677,057 |
Premium* |
|
Voyager Therapeutics, Inc. |
VYGR |
Former 10% owner |
2015-11-10 |
0 |
2015-11-16 |
2,477,941 |
Premium* |
|
Fulcrum Therapeutics, Inc. |
FULC |
10% Owner |
2019-07-22 |
0 |
2019-07-22 |
558,035 |
Premium* |
|
Inozyme Pharma, Inc. |
INZY |
10% Owner |
2020-07-28 |
0 |
2020-07-28 |
520,125 |
Premium* |
|
Icosavax, Inc. |
ICVX |
10% Owner |
2021-08-02 |
0 |
2021-08-02 |
3,155,169 |
Premium* |
|
Translate Bio, Inc. |
TBIO |
10% Owner |
2021-09-14 |
75,668,031 |
2021-09-14 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
85 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 3 of 4
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
REGN |
Regeneron Pharmaceuticals... |
10% Owner |
|
2014-07-08 |
4 |
AB |
$309.33 |
$47,685,743 |
I/I |
153,000 |
21,405,741 |
0 |
- |
|
REGN |
Regeneron Pharmaceuticals... |
10% Owner |
|
2014-07-14 |
4 |
AB |
$314.52 |
$47,726,797 |
I/I |
150,000 |
22,075,741 |
0 |
- |
|
REGN |
Regeneron Pharmaceuticals... |
|
|
2019-09-10 |
4 |
S |
$281.15 |
$48,611,804 |
D/D |
(172,904) |
20,550,813 |
0 |
- |
|
REGN |
Regeneron Pharmaceuticals... |
|
|
2017-08-24 |
4 |
B |
$474.86 |
$51,009,572 |
I/I |
105,820 |
23,808,159 |
2.64 |
- |
|
REGN |
Regeneron Pharmaceuticals... |
10% Owner |
|
2014-10-15 |
4 |
AB |
$323.90 |
$51,970,265 |
I/I |
158,368 |
22,535,558 |
0 |
- |
|
REGN |
Regeneron Pharmaceuticals... |
|
|
2019-03-08 |
4 |
S |
$412.17 |
$54,041,316 |
D/D |
(131,115) |
20,723,717 |
0 |
- |
|
REGN |
Regeneron Pharmaceuticals... |
10% Owner |
|
2014-07-10 |
4 |
AB |
$306.77 |
$54,439,073 |
I/I |
175,000 |
21,775,741 |
0 |
- |
|
REGN |
Regeneron Pharmaceuticals... |
10% Owner |
|
2014-02-04 |
4 |
B |
$282.05 |
$54,504,789 |
I/I |
190,286 |
16,374,131 |
1.5 |
- |
|
REGN |
Regeneron Pharmaceuticals... |
10% Owner |
|
2014-02-03 |
4 |
B |
$279.14 |
$56,141,719 |
I/I |
198,058 |
16,183,845 |
1.5 |
- |
|
REGN |
Regeneron Pharmaceuticals... |
10% Owner |
|
2014-05-19 |
4 |
B |
$296.08 |
$57,233,716 |
I/I |
190,751 |
20,208,841 |
1.5 |
- |
|
REGN |
Regeneron Pharmaceuticals... |
10% Owner |
|
2014-02-05 |
4 |
B |
$274.64 |
$58,367,107 |
I/I |
206,978 |
16,581,109 |
1.5 |
- |
|
REGN |
Regeneron Pharmaceuticals... |
10% Owner |
|
2014-06-30 |
4 |
AB |
$275.68 |
$60,010,479 |
I/I |
212,400 |
20,471,241 |
0 |
- |
|
REGN |
Regeneron Pharmaceuticals... |
10% Owner |
|
2014-03-11 |
4 |
B |
$328.82 |
$60,043,336 |
I/I |
180,710 |
17,773,841 |
1.5 |
- |
|
REGN |
Regeneron Pharmaceuticals... |
10% Owner |
|
2014-07-09 |
4 |
AB |
$304.19 |
$60,112,311 |
I/I |
195,000 |
21,600,741 |
0 |
- |
|
ALNY |
Alnylam Pharmaceuticals I... |
10% Owner |
|
2015-01-26 |
4 |
B |
$95.00 |
$61,507,560 |
I/I |
647,448 |
9,954,485 |
1.5 |
- |
|
REGN |
Regeneron Pharmaceuticals... |
|
|
2020-03-09 |
4 |
S |
$489.65 |
$63,123,153 |
D/D |
(128,914) |
20,421,899 |
0 |
% |
|
REGN |
Regeneron Pharmaceuticals... |
10% Owner |
|
2014-07-01 |
4 |
AB |
$285.89 |
$63,761,421 |
I/I |
212,400 |
20,683,641 |
0 |
- |
|
REGN |
Regeneron Pharmaceuticals... |
|
|
2017-06-02 |
4 |
B |
$466.38 |
$65,055,558 |
I/I |
136,050 |
23,641,744 |
2.64 |
- |
|
REGN |
Regeneron Pharmaceuticals... |
10% Owner |
|
2014-07-02 |
4 |
AB |
$298.91 |
$65,259,552 |
I/I |
212,400 |
20,896,041 |
0 |
- |
|
REGN |
Regeneron Pharmaceuticals... |
10% Owner |
|
2014-03-10 |
4 |
B |
$325.34 |
$65,687,435 |
I/I |
199,822 |
17,593,131 |
1.5 |
- |
|
REGN |
Regeneron Pharmaceuticals... |
10% Owner |
|
2014-12-23 |
4 |
B |
$384.43 |
$67,251,142 |
I/I |
171,457 |
22,829,142 |
1.5 |
- |
|
REGN |
Regeneron Pharmaceuticals... |
|
|
2020-06-09 |
4 |
S |
$597.48 |
$71,837,410 |
I/I |
(120,234) |
279,766 |
0 |
% |
|
REGN |
Regeneron Pharmaceuticals... |
10% Owner |
|
2014-03-12 |
4 |
B |
$325.40 |
$73,964,412 |
I/I |
220,995 |
17,994,836 |
1.5 |
- |
|
REGN |
Regeneron Pharmaceuticals... |
10% Owner |
|
2015-09-23 |
4 |
B |
$523.43 |
$78,708,570 |
I/I |
147,209 |
23,016,992 |
1.5 |
- |
|
REGN |
Regeneron Pharmaceuticals... |
10% Owner |
|
2014-07-07 |
4 |
AB |
$311.17 |
$80,320,795 |
I/I |
256,700 |
21,252,741 |
0 |
- |
|
85 Records found
|
|
Page 3 of 4 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|